Trial Profile
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost/brimonidine/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Allergan
- 03 Dec 2015 New trial record